Vanguard disaggregates holdings; Omnicell (NASDAQ: OMCL) shows 0% stake
Rhea-AI Filing Summary
The Vanguard Group filed an amendment to its Schedule 13G/A reporting 0% beneficial ownership of Omnicell Inc. common stock. The filing states that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries and business divisions will report holdings separately in reliance on SEC Release No. 34-39538. The amendment, signed on March 27, 2026, lists 0 shares beneficially owned and 0% of the class, with no sole or shared voting or dispositive power.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings and now reports zero beneficial ownership in Omnicell.
The amendment records 0 shares and 0% ownership as of the filing, and cites an internal realignment on January 12, 2026 under SEC Release No. 34-39538. This indicates reporting responsibility shifted to subsidiaries or business divisions rather than a change in underlying investment strategy.
The practical effect is administrative: cash‑flow treatment and any subsidiary holdings are not described in this excerpt. Subsequent filings by the disaggregated entities may show actual positions; timing and amounts for those reports are not provided here.
FAQ
What did The Vanguard Group report for OMCL in this Schedule 13G/A?
Who signed the Schedule 13G/A amendment for Vanguard?